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benefits: First, the filling of the LV cavity
during diastole will maintain RV geometry.
(This was indicted in the article by the
displacement of the septum with LV filling,
Figure 5). This more physiologic shape in
diastole may affect the compliance of the
right ventricle with subsequent beneficial
effects on wall tension and subendocardial
perfusion. Again, the use of the diastolic
pressure-volume curve may identify this.
Second, LV ejection will add pulsatility to
the systemic arterial supply, which may
allow greater perfusion at marginal pres-
sure gradients.
Mark H. Danton, MD
Cardiac Surgical Department
Royal Group of Hospitals
Belfast, Northern Ireland BT12 6BA,
United Kingdom
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Reply to the Editor:
My colleagues and I appreciate the ques-
tions raised by Danton in his letter to the
Editor. The relationship between maximum
right ventricular (RV) function and sys-
temic pressure was suggested in 1955 by
Peter Salisbury.1 On the basis of this early
study, we2 demonstrated that, at the onset
of RV failure, the RV free wall becomes
ischemic, and this ischemia and failure can
be reversed by raising systemic pressure.
Although we believed that the entire matter
was simply an issue of RV perfusion, ad-
ditional studies from our laboratory began
to cast doubt on this hypothesis. Page and
associates,3 using a model in which the
right coronary circulation perfuses only the
RV free wall, demonstrated that the maxi-
mal pressure developed by the right ventri-
cle is determined primarily by maximal
developed left ventricular (LV) pressure,
and not by right coronary perfusion pres-
sure. The issue of RV free wall versus left
heart contribution was further explored by
Damiano and colleagues4 in a model in
which the RV free wall was electrophysi-
ologically isolated from the rest of the
heart. They demonstrated two distinct con-
tributions to global RV function: one de-
rived from RV free wall contraction and
one derived from contraction of the left
side of the heart. On the basis of these
studies, we undertook the study recently
published by Klima and coworkers5 to in-
vestigate further the nature of left heart
contribution to RV function.
Putting together the findings of our re-
cent study with the prior work has led us to
conclude that approximately half of RV
function is derived from the contribution of
the free wall, which is dependent on perfu-
sion pressure, combined with a significant
contribution from the left side of the heart,
that is, via the interventricular septum. Fur-
thermore, in our study, even when no LV
preload was introduced into the left ventri-
cle, the ventricle still developed pressure
because of blood returning to the left side
of the heart through the thebesian vessels;
in our preparation, peak developed LV
pressure closely correlated with aortic pres-
sure, irrespective of left heart output. Al-
though we do not deny the role of RV free
wall ischemia in the pathogenesis of RV
failure, we do maintain that the process is
complex with multiple determinants.
Irrespective of mechanism, our study
supports the physiologic principle that de-
veloped LV pressure, and hence systemic
pressure, must be maintained when treating
patients with RV failure.
Gus J. Vlahakes, MD
Massachusetts General Hospital
55 Fruit St—BUL 119
Boston, MA 02114-2696
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Thymolipomas with myasthenia
gravis in Japan
To the Editor:
With great interest we read the article,
“Thymolipoma in Association With Myas-
thenia Gravis,” by Zambudio and col-
leagues.1 They reviewed 18 case reports
about thymolipoma with myasthenia gra-
vis, including 3 Japanese cases.
We also reviewed 14 case reports about
thymolipoma with myasthenia gravis in
1993.2 To our knowledge, there are 9 cases
in Japan, including our new case (Table
1).2-4 The patients comprised 2 men and 7
women, with a mean age of 50  14 years
(29-76 years). The mean thymolipoma
weight was 385  355 g (55-850 g).
Thymolipomas with myasthenia gravis ap-
pear in older patients and are smaller than
thymolipomas without myasthenia gravis
(mean age 34  18 years, mean weight
640  650 g) according our previous re-
view.5
As Zambudio and colleagues discussed
in their comment, we think the best current
surgical treatment for thymolipoma with
myasthenia gravis is extended thymecto-
my.2 We also think that extended thymec-
tomy is the preferable surgical treatment
for thymolipoma even without myasthenia
gravis, since patients with thymolipoma
may have a high titer of serum antiacetyl-
choline receptor antibodies.5
We thank Zambudio and colleagues for
calling attention to this subject.
Mitsuhiro Yamamura, MD, FICA
Takashi Miyamoto, MD, FICA
Hideki Yao, MD
Department of Thoracic &
Cardiovascular Surgery
Hyogo College of Medicine
1-1 Mukogawa-cho, Nishinomiya-city
Hyogo 663-8501, Japan
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Reply to the Editor:
We read with great interest the letter to the
Editor from Yamamura, Miyamoto, and
Yao in response to our article, in which
reference is made to the Japanese experi-
ence in this matter. Our interest in this rare
association arose when in our daily routine
we encountered 3 patients with this condi-
tion and were uncertain of the best ap-
proach and follow-up. Accordingly, we an-
alyzed the bibliography to which we had
access and observed several difficulties,
due not only to the diverse nature of the
journals, some of which are difficult to
locate, but also to the number of different
languages in which they are published. To-
day, the only information that exists for
physicians with scientific curiosity is the
material to which they have access, that is,
that which is available in their own lan-
guage and particularly publications in En-
glish, which now is the scientific language
of reference. It must be remembered that
the journals with the greatest impact, cir-
culation, and scientific rigour are those that
appear in English. Information in non–En-
glish-language journals is usually relegated
to local (nationwide) distribution. This
means that the best studies will not be
published in these local journals, as they
have no impact on the scientific population,
and will be sent to more prestigious jour-
nals. Moreover, articles that have not been
accepted in impact journals often end up in
the local literature. This may occasionally
lead to the submission of lower-quality
studies, and to the scientific committees of
these journals demanding less scientific ri-
gour in order to meet a minimum volume
of articles.
On this basis, we are convinced that the
18 cases of myasthenia gravis in thymoli-
poma that we reviewed represent just the
tip of the iceberg of cases throughout the
world. The problem is that not all cases are
documented. Publishing an article requires
dedication and bibliographic research, and
if it is to be submitted to an English-lan-
guage journal, many of us need to have it
translated into English. All this involves
time and nonremunerated dedication, gen-
erally at the expense of time spent with the
family. We believe it is important to take
advantage of the effort made by
Yamamura, Miyamoto, and Yao to review
all the cases in Japan, because they have
almost doubled the number of cases known
and available to the scientific community.
We are aware of the rigorousness and se-
riousness of Yamamura’s work, both clin-
ical and scientific, and can therefore vouch
for the data that his group reports. We all
believed that there were more cases of this
association in the world and therefore con-
sider that the message of Yamamura, Miy-
amoto, and Yao should not be limited to
saying there are 14 cases more. If their
contribution is to be of interest to the sci-
entific community, I would recommend
that they include a more complete table to
enable us to draw conclusions from the
findings. I believe, for example, that the
table should include at least the following:
author, age, sex, preoperative evolution,
thymolipoma weight, postoperative evolu-
tion, relapse, and follow-up time. A table
of this kind in an impact journal such as
The Journal of Thoracic and Cardiovascu-
lar Surgery would allow such information
to reach most of the scientific community
engaged in thoracic and cardiovascular sur-
gery and would help all of us with an
interest in the subject to broaden our
knowledge of this association.
Antonio Rios Zambudio, MD
Juan Torres Lanzas, MD
Maria Jose´ Roca Calvo, MD
Department of Surgery and Department of
Thoracic Surgery
Virgen de Ia Arrixaca University Hospital
Murcia, Spain
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TABLE 1. Reviews of thymolipoma with myasthenia gravis in Japan
Author Age (y), sex Weight (g) Osserman
Tsuchiya (1965) 45, F — —
Miyairi and Iizuka (1984) 48, F 850 IV
Yamanaka (1987) 55, F 186 IIb
Hongo (1987) 76, F 156 IIa
Hirai (1988) 40, F — IIb
Narita and Toyama (1991) 48, F 680 —
Yamamura (1991) 65, F — I
Takamori and Hayashi (1997) 29, F 55 —
Okumura (2001) 41, M — IIb
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